The global asthma spacers market is anticipated to be driven by technological advancements and increase in use of spacers with metered dose inhalers for the management of asthma. The asthma spacers market in Asia Pacific is expected to expand at a high CAGR of 4.2% due to high prevalence of diseases, development in the health care sector, and increase in focus on research and development.
To garner compelling insights on the forecast analysis of Asthma Spacers Market, Request a PDF Sample Here -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=39410
Rise in Patient Pool for Asthma
According to the WHO, around 235 million people are affected by asthma, and by the end of 2025, the number is likely to rise by 100 million globally. Rise in the prevalence rate of asthma is creating a significant socioeconomic impact across the globe, which, in turn, is propelling the demand for asthma spacers.
Rise in Adoption of Asthma Spacers Drives Market
Inhalation is the first line administration route in asthma management. However, poor inhalation techniques have led to poor disease control and increased health care costs. It is estimated that MDI without spacers, at best, delivers around 20% of the emitted dose to the lower airways, leaving up to 80% in the oropharynx. With suboptimal or incorrect techniques, this fraction is further reduced, potentially to zero. While using asthma spacers, the velocity at which the medication leaves the MDI (estimated at 60mph) is slowed down substantially. It also allows the propellant to evaporate, leaving only the smaller particles, which have a better chance of reaching the smaller airways. Use of spacers/valve holding chambers minimizes issues related to the inhalation technique. It reduces oropharyngeal deposition and increases lung deposition, which, in turn, boosts the adoption of asthma spacers for the proper management of asthma.
Increase in Prevalence of Asthma in Asia Pacific to Create Opportunities in Market
In terms of region, the global asthma spacers market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to constitute a leading share of the global market during the forecast period, owing to high adoption of asthma spacers and high health care expenditure. Europe is anticipated to account for a significant share of the global market between 2018 and 2026.
Increase in the incidence of asthma, rise in awareness about the use of asthma spacers, and increase in government initiatives that mandate the use of asthma spacers with metered dose inhalers are expected to fuel the growth of the market in the region during the forecast period. The market in Asia Pacific is likely to expand at a rapid pace during the forecast period, due to a rise in health care expenditure. Moreover, increase in focus of key players on expansion in Asia Pacific, a large untapped population, and rise in awareness about asthma spacers in Asia Pacific are likely to boost the market. The asthma spacers market in Latin America and Middle East & Africa is anticipated to expand at a steady pace from 2018 to 2026.
